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Background: MicroRNAs (miRNAs) have been reported to play an important role in tumorigenesis. In this study, the
role of miR-15a and miR-16-1 in gastric adenocarcinoma (GAC) was investigated.
Methods: The expression of miR-15a and miR-16-1 in cell lines and primary tumors was examined by miRNA
qRT-PCR. Proliferative assays, colony formation, cell invasion and migration, flow cytometry analysis and in vivo study
were performed by ectopic expression of miR-15a and miR-16-1. The putative target genes of miR-15a and miR-16-
1 were explored by TargetScan and further validated.
Results: We found that miR-15a and miR-16-1 were down-regulated in GAC cell lines and primary tumor samples
compared with normal gastric epithelium. Functional study demonstrated that ectopic expression of miR-15a and miR-
16-1 suppressed cell proliferation, monolayer colony formation, invasion and migration, and xenograft formation in vivo.
In addition, miR-15a and miR-16-1 induced G0/G1 cell cycle arrest which was further confirmed by Western blot and
qRT-PCR of related cell cycle regulators. YAP1 was confirmed to be a functional target of miR-15a and miR-16-1 in GAC.
YAP1 re-expression partly abrogated the inhibitory effect of miR-15a and miR-16-1 in GAC cells. In clinical samples,
YAP1 protein expression shows negative correlation with miR-15a and miR-16-1 expression.
Conclusion: In conclusion, targeting YAP1 by tumor suppressor miRNA miR-15a and miR-16-1 plays inhibitory effect
and this might have a therapeutic potential in GAC.
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Gastric adenocarcinoma (GAC) is one of the most com-
mon malignancies worldwide, with a higher incidence in
eastern Asian countries including China, Japan and
South Korea. Several risk factors are involved in GAC
tumorigenesis including Helicobacter Pylori infection,
high-salt and smoked diet, smoking and chronic gastritis
[1]. The genetic and epigenetic alterations of oncogenes,
tumor suppressor genes and mismatch repair genes were
found to play a role in gastric tumorigenesis. The tumor* Correspondence: kfto@cuhk.edu.hk
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unless otherwise stated.suppressor genes such as B cell CLL/lymphoma 6 mem-
ber B (BCL6B) [2] and paired box gene 5 (PAX5) [3]
were epigenetically inactivated in GAC. Some oncogenes
including Stathmin 1 (STMN1) [4] and Yin Yang 1
(YY1) [5] have been reported to be over-expressed in
GAC and correlated with poor survival in GAC.
MicroRNAs (miRNAs) recently have been identified as
one of the crucial players in carcinogenesis through
post-transcriptional regulation of their target genes [6].
miRNA is a class of small non-coding RNAs which func-
tion as regulators of gene expression through specific
binding to the miRNA recognition elements (MREs) on
the 3′ untranslated regions (UTRs) of target mRNAs.
This results in mRNA degradation or translational re-
pression. Emerging evidence shows that miRNAs are ab-
normally expressed in various cancers and thehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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initiation, promotion and progression. Either overexpres-
sion of oncogenic miRNAs or downregulation of tumor
suppressor miRNAs can promote tumorigenesis.
The most highly expressed miRNAs in GAC were miR-
20b, miR-17, miR-18a and miR-21 whereas miR-768-3p,
miR-139-5p, miR-31 and miR-195 showed decreased ex-
pressions [7]. Some miRNAs with tumor suppressor func-
tion were identified in GAC such as miR-610 targeting
VASP [8], miR-7 targeting IGF1R [9], miR-625 targeting
ILK [10] and let-7 targeting AKT2 [11].
We also performed miRNA expression microarray
screening in 7 GAC cell lines (Additional file 1: Table
S1) and miR-15a and miR-16-1 were screened out to be
dramatically decreased in expression compared with
normal gastric epithelium (Additional file 2: Table S2).
This was further validated by miRNA qRT-PCR. Al-
though miR-15 and miR-16-1 have been reported to play
a role in the development of multi-drug resistance
(MDR) of GAC cells at least by modulating apoptosis via
targeting BCL2 [12], the functional role and other down-
stream targets of miR-15a and miR-16-1 are still not well
elucidated in GAC. Therefore, we aimed to investigateFigure 1 miR-15a and miR-16-1 show decreased expression in GAC. (A
compared with GES-1 cells. The standard deviations (SDs) were achieved b
in paired primary GAC samples (n = 60; miR-15a, P = 0.011; miR-16-1, P < 0.0the functional roles of miR-15a and miR-16-1 and to
identify their novel target gene in gastric carcinogenesis.
Results
miR-15a and miR-16-1 are down-regulated in GAC
miR-15a and miR-16-1 showed decreased expression in
7 and 9 gastric cancer cell lines respectively compared
with immortalized gastric epithelium cell lines GES-1
(Figure 1A). In 60 paired primary GAC samples, miR-
15a and miR-16-1 showed downregulation in adenocar-
cinoma compared with corresponding adjacent non-
tumorous mucosae (miR-15a, mean value: 1.23 Vs 3.25,
P = 0.011; miR-16-1, mean value: 193.2 Vs 517.9, P <
0.001; Figure 1B).
Ectopic expression of miR-15a and miR-16-1 exerts tumor
suppressor function
Ectopic expression of miR-15a and miR-16-1 in gastric
cancer cells was conducted for observation of the pheno-
type changes. qRT-PCR revealed that miR-15a and miR-
16-1 increased to 16.4 ~ 63.8 folds in overexpression
group compared with negative control group (Additional
file 3: Figure S1A). Ectopic expression of miR-15a and) The expression of miR-15a and miR-16-1 in 10 GAC cell lines
y the values in triplicate wells. (B) Expression of miR-15a and miR-16-1
01).
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MGC-803 in a 5-day MTT proliferation assay (P < 0.001,
Figure 2A). The proliferative suppression effect of miR-
15a and miR-16-1 was further validated by monolayer col-
ony formation with a significant reduction of colony num-
bers in miR-15a and miR-16-1 transfectants compared
with the negative groups (P < 0.001, Figure 2B). Ectopic
expression of miR-15a and miR-16-1 resulted in G0/G1
cell cycle arrest and reduction of S phase cells (Figure 2CFigure 2 miR-15a and miR-16-1 exert tumor suppressor function in G
expression in AGS, MKN1 and MGC-803 cells (**, P < 0.001). The P-Value wa
expression of miR-15a and miR-16-1 inhibited monolayer colony formation
performed in triplicate wells to get SDs. (C) Flow cytometry analysis of miR
transfectants. Two independent experiments were performed and the repr
invasion through matrigel (**, P < 0.001). Representative images of cell inva
counted and calculated to get SDs. (E) miR-15a-MGC-803 and miR-16-1-MG
0.001). The tumor sizes in the Day 24 were calculated for the P-Value. (F) W
cleaved-PARP after miR-15a and miR-16-1 transfection.and Additional file 3: Figure S1B). In addition, miR-15a
and miR-16-1 overexpression induced senescence which
was representative by the beta-Galactosidase positive
staining in a 3-day transfection assay (Additional file 3:
Figure S1C). miR-15a and miR-16-1 significantly sup-
pressed the invasion (P < 0.001, Figure 2D) and migration
(Additional file 3: Figure S1D) abilities of GAC cells. To
further explore the role of miR-15a and miR-16-1 on
tumor growth in vivo, MGC-803 cell line which couldAC. (A) MTT proliferation results of ectopic miR-15a and miR-16-1
s calculated by the 575 nm absorbance readings in Day 5. (B) Ectopic
in AGS, MKN1 and MGC-803 cells (**, P < 0.001). The experiment was
-15a and miR-16-1 transfectants compared with scramble miRNA
esentative one was shown. (D) miR-15a and miR-16-1 suppressed cell
sion were also shown. The invaded cells in 3 random vision fields were
C-803 formed smaller tumors than scramble-miRNA-MGC-803 (**, P <
estern blot analysis of CCND3, CCNE1, CDK6, p21, p27, p-Rb and
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ectopic miR-15a and miR-16-1 expression were inoculated
into the dorsal flank of nude mice. 24 days later, the xeno-
grafts with miR-15a and miR-16-1 overexpression were sig-
nificantly smaller than the control group (P < 0.001,
Figure 2E). The associated cell cycle regulators were also
analyzed by Western blot. Expressions of CCND3, CCNE1,
CDK6 and p-Rb were decreased but p21 and p27 were uni-
formly showed up-regulated in miR-15a/miR-16-1 ectopic
expression cells (Figure 2F), supporting the G0/G1-phase
cell cycle arrest determined by cell cycle analysis. However,
the cleaved-PARP only showed activated in AGS and
MGC-803 cells, suggesting that miR-15a and miR-16-1 in-
duced late apoptosis in a cell dependant manner. TheFigure 3 YAP1 is a target of miR-15a and miR-16-1 in GAC. (A) The m
predicted (www.targetscan.org). (B) The YAP1 mRNA expression after ectop
N87 cells (**, P < 0.001). (C) miR-15a and miR-16-1 transfection down-regula
suppressed the luciferase activities in the constructs containing wild-type b
deletion binding sites, miR-15a and miR-16-1 had no suppressive effect on
YAP1 protein expression (P = 0.048). (E2) miR-16-1 expression was negativemRNA expression of some proliferation and invasion re-
lated genes such as CCND3, CCNE1, Ki-67 and MMP3
were all down-regulated in miR-15a/miR-16-1 overexpres-
sion group (Additional file 3: Figure S1E), elucidating the
tumor-suppressive functions of miR-15a and miR-16-1 in
gastric tumorigenesis.
YAP1 is a direct target of miR-15a and miR-16-1 in GAC
By TargetScan (www.targetscan.org) several putative tar-
gets including YAP1 were found to have miR-15a and
miR-16-1 binding site in their 3′UTR. Figure 3A demon-
strated the two miR-15a and miR-16-1 binding sites in
YAP1 3′UTR. The YAP1 mRNA expression showed sig-
nificantly decreased in AGS, MKN1, MGC-803 andiR-15a and miR-16-1 binding sites in YAP1 3′UTR as TargetScan
ic miR-15a and miR-16-1 expression in AGS, MKN1, MGC-803 and NCI-
ted YAP1 protein expression in GAC cells. (D) miR-15a and miR-16-1
inding sites in YAP1 3′UTR, but for the constructs containing the
the luciferase activities. (E1) miR-15a showed negative correlation with
ly correlated with YAP1 protein expression (P = 0.010).
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pression (P < 0.001, Figure 3B). YAP1 protein was also uni-
formly down-regulated after miR-15a/miR-16-1
transfection in all 4 GAC cell lines (Figure 3C). To investi-
gate whether YAP1 is a direct target of miR-15a and miR-
16-1, the constructs encompassing the wild type binding
site in YAP1 3′UTR or deletion counterpart were co-
transfected with Renilla luciferase vector into MGC-803
cells. As shown in Figure 3D, miR-15a and miR-16-1 de-
creased the luciferase activity in the constructs containing
wild type binding site (miR-15a, binding site 1, P = 0.035,
binding site 2, P = 0.006; miR-16-1, binding site 1, P =
0.013, binding site 2, P < 0.001), whereas the luciferase ac-
tivities of the constructs with binding site-deletion showed
no difference upon miR-15a and miR-16-1 expression
compared with negative control. These results revealed
that miR-15a and miR-16-1 directly bind with YAP1 3′
UTR. To further validate the translational suppressive ef-
fect of miR-15a and miR-16-1 on YAP1, the anti-miR-15a
and anit-miR-16-1 were transfected in two immortalized
gastric epithelial cells, GES-1 and HFE-145. We found
YAP1 protein showed up-regulated expression upon
ectopic expression of anti-miR-15a and anti-miR-16-1
(Additional file 4: Figure S2), suggesting that YAP1 high-
expression was partly due the down-regulation of miR-15a
and miR-16-1. To fully recapitulate the intrinsic regulation
of miR-15a and miR-16-1 on YAP1, MKN45, a cell line
with negative YAP1 expression due to homozygous dele-
tion, was used for co-transfection of YAP1 cDNA con-
struct devoid of 3′UTR with miR-15a/miR-16-1. YAP1
protein was found no change in MKN45 after co-
transfection (Additional file 5: Figure S3), suggesting that
miR-15a and miR-16-1 regulate YAP1 expression through
binding to its 3′UTR. As miR-15a and miR-16-1 showed
decreased expression whereas YAP1 showed up-regulated
expression in GAC, the expression correlations of miR-
15a and miR-16-1 on YAP1 were investigated in 28 paired
fresh tissues. YAP1 protein expression shows negatively
correlation with miR-15a (P = 0.048, Figure 3E1) and miR-
16-1 (P = 0.010, Figure 3E2). This result indicated that the
downregulation of miR-15a and miR-16-1 was partly re-
sponsible for endogenous YAP1 overexpression in GAC.
YAP1 knowdown phenocopies ectopic expression of
miR-15a and miR-16-1
As YAP1 is a direct target of miR-15a and miR-16-1 in
GAC, we then checked if siRNA-mediated knockdown
phenocopied the tumor-suppressive function of miR-15a
and miR-16-1. Knocking down YAP1 suppressed in vitro
cell proliferation in MGC-803, NCI-N87 and SGC-7901
cells (P < 0.001, Figure 4A). siYAP1-MGC-803 formed
smaller xenografts than the siScramble-MGC-803 con-
trol in a 28-day in vivo study (P < 0.001, Figure 4B).
Meanwhile, the related cell cycle regulators CCND3,CDK6 and p-Rb showed down-regulated expression but
p21 and p27 showed up-regulated expression upon
siYAP1 transfection (Figure 4C). As the same, cleaved-
PARP only showed activated expression in AGS and
MGC-803 cells, which was similar with the changes of
miR-15a and miR-16-1 ectopic expression.
YAP1 re-expression partly abolishes the tumor-
suppressive effect of miR-15a and miR-16-1
YAP1 re-expression in rescuing the suppressive pheno-
types of cancer cells by ectopic expression of miR-15a
and miR-16-1 was investigated. Interestingly, the growth
inhibitory phenotypes were partly alleviated by YAP1 re-
expression in NCI-N87 and MGC-803 cells (MTT pro-
liferation assay, P < 0.05, Figure 5A; monolayer colony
formation assay, P < 0.05, Figure 5B). The invasion-
inhibitory effects of miR-15a and miR-16-1 were also
partially diminished by YAP1 re-expression (P < 0.05,
Figure 5C).
Discussion
In this study, it was first discovered that miR-15a and
miR-16-1 were consistently down-regulated across a
panel of GAC cells compared with normal gastric epi-
thelium, which suggested their potential roles in gastric
tumorigenesis. In 9 gastric cancer cells, we compared
miR-15a and miR-16-1 expression with the DNA copy
number change of their loci (in 13q14.2, from array-
CGH result of gastric cancer cell lines) and found their
expression shows no positive correlation the DNA copy
number change (Additional file 6: Figure S4A). We also
treated the gastric cancer cells with 5-Aza and TSA to
investigate if epigenetic modification is responsible for
the downregulation of miR-15a/16-1 in GAC, however,
miR-15a and miR-16-1 showed no significant expression
change (>2 fold change) upon treatment in NCI-N87
and MGC-803 cells (Additional file 6: Figure S4B). So
the mechanisms of miR-15a and miR-16-1 downregula-
tion in GAC need further investigation. Ectopic expres-
sion of miR-15a and miR-16-1 exerted tumor suppressor
function by inhibiting GAC cell proliferation in vitro
and in vivo, inhibiting cell invasion and migration, in-
duced G0/G1 phase cell cycle arrest even caused senes-
cence. These functional studies suggested that miR-15a
and miR-16-1 played a crucial role in cellular homeosta-
sis, when dysregulated, might contribute to the develop-
ment of GAC.
miR-15a and miR-16-1, encoded by the miR-15/16-1
cluster, were identified as tumor suppressors . Expres-
sion of these miRNAs inhibits cell proliferation, pro-
motes apoptosis of cancer cells and suppresses
tumorigenicity both in vitro and in vivo [13]. Downregu-
lation of these two miRNAs has been well elucidated in
chronic lymphocytic lymphoma (CLL) [14]. Deletions in
Figure 4 siRNA-mediated YAP1 knockdown suppressed GAC cell proliferation in vitro and in vivo. (A) YAP1 knockdown suppressed cell
proliferation in MGC-803, NCI-N87 and SGC-7901 cells (**, P < 0.001). The 575 nm absorbance readings in Day 6 were calculated for the P-Value.
(B) siYAP1-MGC-803 formed smaller xenografts than siScramble-MGC-803 control in nude mice (**, P < 0.001). The tumor sizes in the Day 28 were
calculated for the P-Value. (C) YAP1 knowdown decreased the expression of CCND3, CDK6 and p-Rb, but increased the expression of p21 and
p27. The cleaved-PARP showed activated expression in AGS and MGC-803 cells upon YAP1 knockdown.
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expression account for the loss of expression of miR-15a
and miR-16-1 in CLL [15]. The miR-15a and miR-16-1
expression were found to be inversely correlated with
BCL2 [16] and WT1 oncogene expression in CLL [17].
miR-15a and miR-16-1 were down-regulated in fibro-
blasts surrounding the prostate tumors and their down-
regulation resulted in the development and progression
of prostate cancer [18]. Up-regulated BCL2, CCND1 and
WNT3A which promote tumorigenic features, are the
main targets of miR-15a and miR-16-1 in prostate can-
cer [19]. In non small cell lung carcinoma (NSCLC),
miR-15a and miR-16-1 cluster regions were frequently
deleted or their expressions were down-regulated. Ex-
pression of miR-15a and miR-16-1 have been found to
inversely correlate with the expression of cell cycle regu-
lators CCND1 and CCNE1 [20]. In addition, these miR-
NAs were shown to induce Rb-dependent cell cycle
arrest in NSCLC [21]. Downregulation of miR-15a has
also been reported to enhance proliferation on pancre-
atic cancer cells [22,23]. Apart from this, miR-15a and
miR-16-1 were able to induce apoptosis of rat pancreatic
stellate cells by inhibiting BCL2 expression [24]. Inovarian cancer, the miR-15a and miR-16-1 levels were
found to be inversely correlated to the protein expres-
sion levels of Bmi-1 which its 3′UTR is the direct target
of these miRNAs [25]. BCL2, an anti-apoptotic protein
and important target of miR-15/16, was also found to be
negatively regulated by miR-15a and miR-16-1 in GAC
(Additional file 3: Figure S1F). Our functional study
enriched the tumor suppressive role of miR-15a and
miR-16-1 in various cancer types.
From the target gene screening, YAP1, which was also
negatively regulated by miR-375 [26], was first identified
as a novel downstream target of miR-15a and miR-16-1
in gastric cancer. Our previous study showed that YAP1
exerted oncogenic function in GAC development by
constitutively activating RAF/MEK/ERK pathway. YAP1
overexpression promoted anchorage independent colony
formation, induced a more invasive phenotype and ac-
celerated cell growth both in vitro and in vivo [27]. Anti-
YAP1 siRNA suppressed cell proliferation, decreased cell
invasion and colony formation ability and induce G0/G1
cell cycle arrest, which resembled the growth-inhibitory
phenotypes of miR-15a and miR-16-1 in GAC cells. We
further confirmed YAP1 re-expression partly abrogated
Figure 5 YAP1 re-expression partly abrogated the inhibitory effect of miR-15a and miR-16-1 in NCI-N87 and MGC-803. (A) YAP1
re-expression increased cell proliferation compared with miR-15a or miR-16-1 alone (*, P < 0.05; **, P < 0.001). The SDs were achieved by the
575 nm absorbance readings in 6 wells of each item. (B) Monolayer colony formation assays revealed YAP1 re-expression abolished proliferation-
inhibition of miR-15a and miR-16-1 partially (*, P < 0.05; **, P < 0.001). The representative colony formation pictures were shown in the bottom. The
experiments was performed in triplicate wells to get SDs. (C) The suppressed cell invasion abilities was partially alleviated by YAP1 re-expression in
NCI-N87 and MGC-803 cells (*, P < 0.05; **, P < 0.001). The cells were counted in 3 random vision fields of each item to get SDs.
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tumors, YAP1 protein expression shows negative correl-
ation with miR-15a and miR-16-1 expression. Collectively,
these data supported that YAP1 was a main target of miR-
15a and miR-16-1 in gastric tumorigenesis.
In summary, our results revealed that miR-15a and
miR-16-1, which functions as tumor suppressors, weredown-regulated in GAC. Ectopic expression of miR-15a
and miR-16-1 suppressed GAC cell proliferation, at least
in partial by targeting YAP1 oncoprotein. These findings
suggested that the frequently down-regulated miR-15a
and miR-16-1 in GAC contributed to GAC progression
and therefore miR-15a and miR-16-1 might have a
therapeutic potential for GAC treatment. At the mean
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post-transcriptional regulation of YAP1 besides the clas-
sic Hippo signaling pathway.Materials and methods
Cell lines and primary gastric cancer tissues
Human GAC cell lines (MKN1, MKN7, MKN28, MKN45,
SNU1, SNU16, AGS, NCI-N87, MGC-803, SGC-7901)
(Additional file 7: Table S3) and two immortalized gastric
epithelial cells (GES-1 and HFE-145) were employed as in
our previous report [4]. Cells were cultured at 37°C in a hu-
midified air atmosphere containing 5% carbon dioxide in
RPMI 1640 medium (GIBCO, Grand Island, NY) supple-
mented with 10% fetal bovine serum (GIBCO) The primary
paired samples (tumor samples and adjacent non-tumorous
samples) from GAC patients were randomly selected from
Prince of Wales Hospital. Ethical approval was obtained
from the Joint Chinese University of Hong Kong-New
Territories East Cluster Clinical Research Ethics Committee
(CREC Ref. No.2009.521).RNA extraction and quantitative real-time polymerase
chain reaction (qRT-PCR)
A total of 32 paired formalin-fixed and paraffin-embedded
and 28 paired frozen GAC samples were included in this
study. Tissues from formalin-fixed and paraffin-embedded
sections were isolated by micro-dissection under micro-
scope and total RNA was extracted using RecoverAll Total
Nucleic Acid Isolation Kit (Ambion, Austin, TX). Total
RNA from fresh tissue samples and cultured cells was ex-
tracted using TRIzol reagent (Invitrogen, Carlsbad, CA),
High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Carlsbad, CA) was used for cDNA synthesis.
qRT-PCR was used to quantify differences in mRNA ex-
pression and primers were listed in Table S4 (Additional
file 8). The relative expression level was normalized by
RPL29 in gastric tissues and B2M in gastric cancer cell lines
[28]. PCR was performed using SYBR Green PCR reagents
(Applied Biosystems) according to the manufacturer’s in-
structions. The reactions were incubated in a 96-well plate
at 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec-
onds and 60°C for 1 minute.
For miRNA expression detection, Taqman miRNA
assays were used to quantify the expression levels of
mature miR-15a and miR-16-1 (000389 and 000391,
Applied Biosystems). The relative expression level of
microRNAs was normalized by RNU6B (001093, Ap-
plied Biosystems). The reactions were performed in
7500 Fast Real-Time System (Applied Biosystems) and
the reaction mix was incubated at 95°C for 30 seconds,
followed by 40 cycles of 95°C for 8 seconds and 60°C
for 30 seconds [11].Protein extraction and Western blot analysis
Protein was extracted from GAC cell lines and paired
primary tissues using RIPA lysis buffer with proteinase
inhibitor. Protein concentration was measured by the
method of Bradford (Bio-Rad, Hercules, CA) and 20 μg
of protein mixed with 2 × SDS loading buffer was loaded
per lane, separated by 12% SDS-polyacrylamide gel elec-
trophoresis. Horseradish peroxidase (HRP) substrate so-
lution was used for signal detection (Millipore, Billerica,
MA). YAP1 protein was detected with a monoclonal
anti-YAP1 antibody (1:10000 dilution, ab52771, Abcam,
Cambridge, MA). Other primary antibodies were ob-
tained from Cell Signaling Technology (Danvers, MA),
CCND3 (1:2000, #2936), CCNE1 (1:1000, #4129), CDK6
(1:2000, #3136), p21 (1:1000, #2946), p27 (1:1000,
#2552), p-Rb(Ser807/811) (1:1000, #9308), cleaved PARP
(Asp214) (1:1000, #9541), BCL2(1:1000, #2870). The sec-
ondary antibodies were anti-Mouse IgG-HRP (1:30000
dilution, 00049039, Dako, Glostrup, Denmark) and anti-
Rabbit IgG-HRP (1:10000, 00028856, Dako). The West-
ern blot bands were quantified by ImageJ.
miRNA/siRNA transfection and functional study
Transfection of miR-15a and miR-16-1 precursors
(PM10235 and PM10339, Applied Biosystems) and scram-
ble control (AM17110) was performed using Lipofectamine
2000 Transfection Reagent (Invitrogen). All transfection
were performed in a 30 nM concentration for 36 hours
followed with functional study and RNA/protein analysis.
MTT cell proliferation was assessed by CellTiter 96 Non-
Radioactive Cell Proliferation Assays (Promega, Madison,
WI) according to manufacturer’s instruction. Four groups
of cells were evaluated: miR-15a, miR-15a precursor trans-
fection; miR-16-1, miR-16-1 precursor transfection; Mock
control, only Lipofectamine; Negative control, scramble
miRNA transfection. For colony formation assays in mono-
layer cultures, cells transfected with miRNA were cultured
for 14 days, fixed with 70% ethanol for 15 minutes and
stained with 2% crystal violet. Colonies with more than 50
cells per colony were counted. The experiments were re-
peated in triplicate to get standard deviations. The cell mi-
gration assays were performed by Transwell Polycarbonate
Membrane Inserts (Corning, NY). The cell invasion assay
using BD Biocoat Matrigel Invasion Chambers (BD Biosci-
ences, Franklin Lakes, NJ) has been described previously
[27]. The functional study of siYAP1 (SI02662954, Qiagen,
Valencia, CA) was also performed as above except that a
concentration of 25 nM siRNA was used.
In the senescence experiments, AGS, MKN1, MGC-
803 cells were transfected with miR-15a, miR-16-1 or
negative control for 3 days in 20 nM concentration.
Then the cells were stained by senescence beta-
Galactosidase (Kit, #9860, Cell Signaling) for 8 hours
and the positive cell population showed pale green. The
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standard deviation was achieved by calculated the ratio
of positive cells per 100 cancer cells in three random vi-
sion fields and normalized by the negative control
group.
For the rescue experiments, miR-15a and miR-16-1
precursors and the negative control were separately
transfected into NCI-N87 and MGC-803 cells. And
24 hours after precursor transfection, YAP1 expression
plasmid (pcDNA3.1-YAP1) or empty vector (pcDNA3.1,
Life Technologies) were subsequently transfected with
FuGENE HD Transfection Reagent (Roche, Nutley, NJ).
After another 24 hours, cells were harvested for func-
tional study (MTT proliferation assays, monolayer col-
ony formation assays and cell invasion assays).
Cell cycle analysis
Cell cycle analysis was performed using flow cytometry
as described previously [5].
In vivo tumorigenicity study
MGC-803 cells (1 × 107 cells suspended in 0.1 ml PBS)
transiently transfected with scramble control or miR-
15a/miR-16-1 were injected subcutaneously into the dor-
sal flank of six 4-week-old Balb/c nude mice. The tumor
diameter was measured and documented to get tumor
volume every 4 days form day 8. 24 days later, the mice
were sacrificed and the xenografts were taken out.
Tumor volume (mm3) was estimated by measuring the
longest and shortest diameter of the tumor and calculat-
ing as follows: volume = (shortest diameter)2 × (longest
diameter) × 0.5.
For siYAP1 in vivo study, the procedures were the
same as above. MGC-803 cells transfected with siYAP1
were implanted on the right dorsal flank and cells trans-
fected with siScramble were implanted on the left dorsal
flank of nude mice. The tumor diameter was docu-
mented every 5 days from day 8 to day 28.
All animal handling and experimental procedures were
approved by Department of Health, Hong Kong (Refer-
ence No: 14–267 in DH/HA&P/8/2/1 Pt.38).
Luciferase assays
The two putative miR-15a and miR-16-1 MREs in YAP1
3′UTR were subcloned into pMIR-REPORT vector
(Ambion). Two deletion constructs were generated by
deletion of the complementary entire seed sequence of
miR-15a and miR-16-1. The sense and anti-sense of oli-
gonucleotides (Additional file 9: Table S5) that encom-
passed the miR-15a and miR-16-1 binding sites were
annealed and inserted into the vector [29]. The firefly lu-
ciferase constructs were co-transfected with the Renilla
luciferase vector (Promega) control into MGC-803 cells
with FuGENE HD Transfection Reagent. Dual LuciferaseReporter Assay System (Promega) was employed to
measure the luciferase activity for normalization 24 hours
after transfection.
Statistical analysis
The Student T test was used to compare the difference
in biological behavior between miR-15a and miR-16-1
transfected cells and scramble miRNA control trans-
fected cells. Expression of miR-15a/miR-16-1 in GAC
cell lines, primary cancerous tissues and the correspond-
ing paired noncancerous tissues were compared by
Mann–Whitney U test and paired T test. The miR-15a/
16-1 expression in gastric cancer cell lines was com-
pared with its copy number change by non-parametric
Spearman’s rho rank test. All statistical analysis was per-
formed by SPSS software (Version 16.0; SPSS Inc). A
two-tailed P-value of less than 0.05 was considered sta-
tistically significant.Additional files
Additional file 1: Table S1. The raw data of miRNA expression
microarray in 7 gastric adenocarcinoma cell lines.
Additional file 2: Table S2. The expression of miR-15a and miR-16-1 in
gastric cancer cells (log2 ratio). The data was from microRNA expression
microarray and normal gastric epithelium control is from Ambion
(AM7996, Grand Island, NY).
Additional file 3: Figure S1. Additional functional study of ectopic
expression of miR-15a and miR-16-1 in gastric cancer cells (*, P < 0.05; **, P<
0.001). (A) qRT-PCR of miR-15a and miR-16-1 in AGS, MKN1 and MGC-803
after ectopic expression. (B) Representative cell cycle distribution images of
FACS flow cytometry analysis in GAC cell lines upon overexpression of
miR-15a and miR-16-1. (C) Overexpression of miR-15a and miR-16-1 induced
senescence in a 3-day transfection assay. (D) The cell migration ability was
significantly inhibited by ectopic expression of miR-15a and miR-16-1. (E)
qRT-PCR analysis of CCND3, CCNE1, Ki67 and MMP3 upon ectopic expression
of miR-15a and miR-16-1. (F) Overexpression of miR-15a and miR-16-1 also
decreased the expression of Bcl-2 protein (a putative target of miR-15a/16-1)
in GAC cell lines, but the autophagy related proteins, p62 and LC3, show no
change.
Additional file 4: Figure S2. anti-miR-15a and anti-miR-16-1 increased
YAP1 protein expression in GES-1 and HFE-145 cells.
Additional file 5: Figure S3. miR-15a and miR-16-1 had no down-
regulation effect on the YAP1 expression in MKN45-YAP1 cells (devoid
YAP1 3′UTR).
Additional file 6: Figure S4. The genetic and epigenetic investigation
of miR-15a and miR-16-1 in GAC. (A) The correlation analysis of miR-15a
and miR-16-1 expression with its copy number change (from array-CGH
data, n = 9; miR-15a, P = 0.802; miR-16-1, P = 0.894). (B) The expression of
miR-15a and miR-16-1 after treatment with 5-Aza and TSA in NCI-N87
and MGC-803 cells.
Additional file 7: Table S3. The biological information of 10 gastric
cancer cell lines.
Additional file 8: Table S4. Primers used in this study.
Additional file 9: Table S5. Oligonucleotides used in the miR-15a/miR-
16-1 targeting YAP1 3′UTR luciferase activity experiments. Wild type,
miR-15a/miR-16-1 binding site in YAP1 3′UTR; Deletion, the complementary
sequence of miR-15a/miR-16-1 seed region was deleted.
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